---
document_datetime: 2025-03-03 15:16:26
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nepexto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: nepexto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.1626088
conversion_datetime: 2025-12-24 19:01:59.80634
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nepexto

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                               |
|----------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0033               | Renewal of the marketing authorisation. | 12/12/2024                          | 12/02/2025                                  | SmPC and PL                      | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Nepexto in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0035/G   | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation   | 05/12/2024   | n/a   |           |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------|
| IAIN/0034   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 23/10/2024   | n/a   |           |
| IB/0032/G   | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.c.2.z - Change in the specification parameters and/or limits of the immediate packaging of the AS - Other variation                                                                                                                                                                                                                                                                       | 18/09/2024   | n/a   |           |
| IA/0031     | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/08/2024   | n/a   | procedure |

<div style=\"page-break-after: always\"></div>

| IB/0030             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                            | 02/08/2024   | 13/01/2025   | SmPC and PL     |                                                                                                                                            |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0027             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                            | 19/12/2023   | 13/01/2025   | SmPC and PL     |                                                                                                                                            |
| IAIN/0029/G         | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.7 - Administrative change - Deletion of manufacturing sites | 15/12/2023   | 13/01/2025   | Annex II and PL |                                                                                                                                            |
| II/0024             | B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                                                                                                                  | 14/12/2023   | n/a          |                 |                                                                                                                                            |
| PSUSA/10795 /202302 | Periodic Safety Update EU Single assessment - etanercept                                                                                                                                                                                                                                                                                                | 12/10/2023   | 11/12/2023   |                 | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10795/202302. |

<div style=\"page-break-after: always\"></div>

| II/0023   | B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                                                                                                                        | 26/10/2023   | n/a        |                        |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| T/0026    | Transfer of Marketing Authorisation                                                                                                                                                                                                                          | 03/08/2023   | 30/08/2023 | SmPC, Labelling and PL |
| IB/0025   | B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line)                            | 07/08/2023   | n/a        |                        |
| IB/0021   | B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                                                                                                                                                 | 12/07/2023   | n/a        |                        |
| IB/0022   | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                          | 11/07/2023   | 30/08/2023 | SmPC                   |
| IB/0019   | B.I.e.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                                                                                                                  | 05/05/2023   | n/a        |                        |
| IB/0018   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 24/01/2023   | 30/08/2023 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

| IB/0017   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                      | 16/09/2022   | 14/10/2022   | SmPC and PL     | To update section 5.1 of the SmPC in order to update clinical information based on final results obtained from a clinical paediatric study.   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0016   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                        | 20/06/2022   | n/a          |                 |                                                                                                                                               |
| IB/0014/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 15/03/2022   | n/a          |                 |                                                                                                                                               |
| IA/0015/G | This was an application for a group of variations. B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)    | 14/03/2022   | 14/10/2022   | Annex II and PL |                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

| II/0011     | B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 02/12/2021   | n/a        |                                  |                 |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------|
| IAIN/0013/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.IV.1.b - Change of a measuring or administration device - Deletion of a device A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or | 01/10/2021   | 14/10/2022 | SmPC, Annex II, Labelling and PL | manufacturer of |
| IB/0012     | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/09/2021   | n/a        |                                  |                 |
| II/0010/G   | This was an application for a group of variations. B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal                                                                                                                                                                                                                                                                                                                                                                                                                     | 16/09/2021   | n/a        |                                  |                 |

<div style=\"page-break-after: always\"></div>

|         | related to a protocol B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line) B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                |            |            |             | product and is not   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------------|
| II/0002 | B.II.b.1.d - Replacement or addition of a manufacturing site for the FP - Site which requires an initial or product specific inspection                                                                                                                                                                                                                                                                                                                                                                                                                                      | 24/06/2021 | n/a        |             |                      |
|         | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 05/05/2021 | 21/06/2021 | SmPC and PL | IB/0009/G            |

<div style=\"page-break-after: always\"></div>

| IB/0008   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 25/03/2021   | n/a        |                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|
| IA/0007/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.I.c.2.b - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 16/02/2021   | n/a        |                       |
| IB/0006   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 21/01/2021   | 21/06/2021 | SmPC, Annex II and PL |
| IB/0005   | B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 09/11/2020   | n/a        |                       |

<div style=\"page-break-after: always\"></div>

| IAIN/0004   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                     | 23/10/2020   | 21/06/2021   | SmPC, Annex II and PL   |                            |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------------|----------------------------|
| IAIN/0003   | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes | 09/09/2020   | 21/06/2021   | SmPC, Labelling and PL  |                            |
| IB/0001     | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside approved pack sizes                           | 07/07/2020   | 21/06/2021   | SmPC, Labelling and PL  | the range of the currently |